Last updated: August 3, 2026
Apollo Pharmacy and MedPlus are India's two largest pharmacy chains, and on paper they look similar — both are branded FOFO franchises with strong national recognition. The real difference shows up in the numbers: Apollo runs a higher-investment, higher-margin model (₹15-30 lakh, 25-30% margin), while MedPlus sits in a slightly lower band with thinner reported margins (₹16-23 lakh, 8-20%). Neither is "better" in the abstract — it depends on your budget and how much weight you put on brand recall versus take-home profit.
Apollo Pharmacy Franchise: The Numbers
Apollo is India's largest pharmacy chain with over 5,000 stores nationwide. Franchise investment typically runs ₹15-30 lakh — a franchise fee of ₹5-10 lakh, a refundable security deposit around ₹2 lakh, interiors of ₹15-20 lakh, and initial inventory of ₹10-12 lakh. Reported operating margins sit around 25-30%, with ROI commonly cited at 12-18 months.
MedPlus Franchise: The Numbers
MedPlus operates over 3,700 stores as of late 2024, concentrated across Tier 1 and Tier 2 cities. The franchise fee runs ₹10-12 lakh, with initial inventory adding another ₹10-15 lakh — a total investment typically in the ₹16-23 lakh range. Reported profit margins run 8-20% of monthly sales, and franchisees in high-density residential areas report monthly sales of ₹8-15 lakh, translating to a take-home income of roughly ₹80,000-1.5 lakh a month after rent, staff, and utilities. ROI is commonly reported at 2-3 years, longer than Apollo's typical payback window.
Side-by-Side Comparison
| Factor | Apollo Pharmacy | MedPlus | AKTICON |
|---|---|---|---|
| Store count | 5,000+ | 3,700+ | Live in 7 states, expanding |
| Typical investment | ₹15–30 lakh | ₹16–23 lakh | ₹10 lakh, all-inclusive |
| Reported margin | 25–30% | 8–20% | No royalty deduction |
| Reported ROI | 12–18 months | 2–3 years | Varies by location |
| Ongoing royalty | Franchise/royalty applies | Franchise fee applies | None — zero royalty |
| Best fit | Metro, larger budget | Tier 1/2, moderate budget | Tier 2/3, first-time owners |
Where Apollo Wins
Apollo's brand recognition is the strongest in the category, and its reported margin (25-30%) and faster payback (12-18 months) make it the stronger pick if your budget comfortably covers ₹15-30 lakh and your target market is a dense, competitive metro area where national brand recall genuinely drives footfall from day one.
Where MedPlus Wins
MedPlus's slightly lower entry investment and deep presence in Tier 1/2 cities make it a reasonable middle-ground choice if Apollo's higher end feels out of reach but you still want a nationally recognised name. The trade-off is a longer reported payback period (2-3 years) and a wider, less predictable margin band (8-20%).
The Question Neither Answers: What Happens to Your Margin Over Time
Both Apollo and MedPlus operate on a franchise-fee structure that continues after you open — meaning a portion of your ongoing revenue or profit is contractually committed to the parent company, indefinitely. Neither figure above accounts for that. Run the two-way math yourself: take your expected monthly revenue, apply the relevant fee percentage, and multiply by 60 months to see the real five-year cost of that ongoing commitment.
This is exactly the gap AKTICON was built to close. Instead of a ₹15-30 lakh (Apollo) or ₹16-23 lakh (MedPlus) investment with an ongoing franchise fee, AKTICON's model is a single, all-inclusive ₹10 lakh — covering branding, 150 sq. ft. interior fit-out, drug license and pharmacist arrangement, initial stock, and a marketing launch — with zero royalty, forever. For a first-time owner in a Tier 2 or Tier 3 city, where over 60% of India's new franchise openings are now happening, that difference compounds into real money over five years. See the full ₹10 lakh breakdown and apply →
If Apollo or MedPlus's numbers feel out of reach, or the ongoing fee doesn't sit right with you, AKTICON's franchise page lays out exactly what's included and what real, currently-open stores look like — with no hidden line items.
FAQ
Is Apollo more profitable than MedPlus? Reported margins are generally higher for Apollo (25-30% vs MedPlus's 8-20%), but Apollo also requires a larger upfront investment — the comparison depends on your capital and target market.
Which one has a faster payback period? Apollo is commonly reported at 12-18 months versus MedPlus's 2-3 years, though both depend heavily on location, footfall, and local competition.
Do Apollo and MedPlus charge an ongoing fee after the franchise opens? Yes, both operate on a franchise-fee structure that continues after opening — this is separate from the initial investment and should be confirmed in writing before signing with either.
Is there a lower-cost alternative to Apollo or MedPlus with no ongoing fee? Yes — AKTICON runs a zero-royalty FOFO model at ₹10 lakh all-inclusive, specifically built for first-time owners in Tier 2/3 cities where brand recall matters less than local trust and transparent pricing.
TL;DR
Apollo suits a larger metro-focused budget with faster reported ROI; MedPlus suits a moderate Tier 1/2 budget with a longer payback window. Both carry an ongoing franchise fee that neither figure accounts for. See the full numbers in Is Apollo Pharmacy Franchise Profitable? and compare every major option in Top Pharmacy Franchise Options in India. Ready for a transparent, zero-royalty alternative? Apply to AKTICON →
About the Author
Anjali Pathak — Team Leader, AKTICON LABORATORIES
Anjali Pathak is part of the AKTICON LABORATORIES leadership team, working directly on franchise growth strategy across its operating states.
Marketing Strategy Partner: Acuminex.com